Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.

Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP, Meyer BJ.

Schizophr Res. 2019 Jul 10. pii: S0920-9964(19)30241-5. doi: 10.1016/j.schres.2019.06.020. [Epub ahead of print]

PMID:
31301881
2.

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

Berger M, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Amminger GP.

Front Psychiatry. 2019 Jun 6;10:393. doi: 10.3389/fpsyt.2019.00393. eCollection 2019.

3.

Detailed analysis of chick optic fissure closure reveals Netrin-1 as an essential mediator of epithelial fusion.

Hardy H, Prendergast JG, Patel A, Dutta S, Trejo-Reveles V, Kroeger H, Yung AR, Goodrich LV, Brooks B, Sowden JC, Rainger J.

Elife. 2019 Jun 4;8. pii: e43877. doi: 10.7554/eLife.43877.

4.

Reducing risk following self-harm: the need for careful prescribing.

Chew-Graham CA, Morgan C, Webb RT, Emery A, Carr MJ, Kontopantelis E, Yung AR, Ashcroft DM.

Br J Gen Pract. 2019 May;69(682):224-225. doi: 10.3399/bjgp19X702317. No abstract available.

PMID:
31023669
5.

Importance of Variable Selection in Multimodal Prediction Models in Patients at Clinical High Risk for Psychosis and Recent-Onset Depression.

Nelson B, Yung AR, McGorry PD.

JAMA Psychiatry. 2019 Feb 6. doi: 10.1001/jamapsychiatry.2018.4234. [Epub ahead of print] No abstract available.

PMID:
30725086
6.

Perceived stress and psychosis: The effect of perceived stress on psychotic-like experiences in a community sample of adolescents.

Turley D, Drake R, Killackey E, Yung AR.

Early Interv Psychiatry. 2019 Feb 3. doi: 10.1111/eip.12795. [Epub ahead of print]

PMID:
30712294
7.

Investigating the Agreement Between Cardiovascular Disease Risk Calculators Among People Diagnosed With Schizophrenia.

Berry A, Drake RJ, Webb RT, Ashcroft DM, Carr MJ, Yung AR.

Front Psychiatry. 2018 Dec 12;9:685. doi: 10.3389/fpsyt.2018.00685. eCollection 2018.

8.

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.

Bolt LK, Amminger GP, Farhall J, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Allott KA.

Schizophr Res. 2019 Apr;206:67-74. doi: 10.1016/j.schres.2018.12.013. Epub 2018 Dec 14.

PMID:
30558978
9.

Dynamic prediction of transition to psychosis using joint modelling.

Yuen HP, Mackinnon A, Hartmann J, Amminger GP, Markulev C, Lavoie S, Schäfer MR, Polari A, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Nelson B.

Schizophr Res. 2018 Dec;202:333-340. doi: 10.1016/j.schres.2018.07.002. Epub 2018 Jul 7.

PMID:
30539771
10.

Can youth at high risk of illness progression be identified by measures of rumination and sleep-wake disturbance.

Grierson AB, Scott J, Glozier N, Hickie IB, Amminger PG, Killackey E, McGorry PD, Pantelis C, Phillips L, Scott E, Yung AR, Purcell R.

Early Interv Psychiatry. 2018 Nov 28. doi: 10.1111/eip.12757. [Epub ahead of print]

PMID:
30485651
11.

Persistent negative symptoms in individuals at Ultra High Risk for psychosis.

Yung AR, Nelson B, McGorry PD, Wood SJ, Lin A.

Schizophr Res. 2019 Apr;206:355-361. doi: 10.1016/j.schres.2018.10.019. Epub 2018 Oct 26.

12.

Longitudinal Cognitive Performance in Individuals at Ultrahigh Risk for Psychosis: A 10-year Follow-up.

Allott K, Wood SJ, Yuen HP, Yung AR, Nelson B, Brewer WJ, Spiliotacopoulos D, Bruxner A, Simmons M, Broussard C, Mallawaarachchi S, Pantelis C, McGorry PD, Lin A.

Schizophr Bull. 2018 Oct 13. doi: 10.1093/schbul/sby143. [Epub ahead of print]

PMID:
30321434
13.

Diet as a hot topic in psychiatry: a population-scale study of nutritional intake and inflammatory potential in severe mental illness.

Firth J, Stubbs B, Teasdale SB, Ward PB, Veronese N, Shivappa N, Hebert JR, Berk M, Yung AR, Sarris J.

World Psychiatry. 2018 Oct;17(3):365-367. doi: 10.1002/wps.20571. No abstract available.

14.
15.

Enhancing social functioning in young people at Ultra High Risk (UHR) for psychosis: A pilot study of a novel strengths and mindfulness-based online social therapy.

Alvarez-Jimenez M, Gleeson JF, Bendall S, Penn DL, Yung AR, Ryan RM, Eleftheriadis D, D'Alfonso S, Rice S, Miles C, Russon P, Lederman R, Chambers R, Gonzalez-Blanch C, Lim MH, Killackey E, McGorry PD, Nelson B.

Schizophr Res. 2018 Dec;202:369-377. doi: 10.1016/j.schres.2018.07.022. Epub 2018 Jul 18.

PMID:
30031616
16.

Women with schizophrenia are at increased risk of breast cancer.

Yung AR, Firth J.

Evid Based Ment Health. 2018 Aug;21(3):e13. doi: 10.1136/ebmental-2018-300019. Epub 2018 Jul 13. No abstract available.

PMID:
30006440
17.

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course.

Nelson B, Amminger GP, Yuen HP, Markulev C, Lavoie S, Schäfer MR, Hartmann JA, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD.

NPJ Schizophr. 2018 Jun 25;4(1):11. doi: 10.1038/s41537-018-0052-x.

18.

Stand-alone cognitive behavioural therapy is not in clinical equipoise with antipsychotic treatment - Author's reply.

Morrison AP, Law H, Shiers D, Yung AR, Haddad PM.

Lancet Psychiatry. 2018 Jul;5(7):540-541. doi: 10.1016/S2215-0366(18)30218-9. No abstract available.

PMID:
29941130
19.

The role of coping in the association between subclinical psychotic experiences and functioning: A within study replication in two independent adolescent samples.

Chisholm KE, Wigman JTW, Hallett D, Woodall T, Mahfouda S, Reniers RLEP, Killackey E, Yung AR, Wood SJ, Lin A.

Schizophr Res. 2018 Nov;201:91-97. doi: 10.1016/j.schres.2018.05.022. Epub 2018 Jun 7.

PMID:
29885966
20.

Association Between Muscular Strength and Cognition in People With Major Depression or Bipolar Disorder and Healthy Controls.

Firth J, Firth JA, Stubbs B, Vancampfort D, Schuch FB, Hallgren M, Veronese N, Yung AR, Sarris J.

JAMA Psychiatry. 2018 Jul 1;75(7):740-746. doi: 10.1001/jamapsychiatry.2018.0503.

21.

Grip Strength Is Associated With Cognitive Performance in Schizophrenia and the General Population: A UK Biobank Study of 476559 Participants.

Firth J, Stubbs B, Vancampfort D, Firth JA, Large M, Rosenbaum S, Hallgren M, Ward PB, Sarris J, Yung AR.

Schizophr Bull. 2018 Jun 6;44(4):728-736. doi: 10.1093/schbul/sby034.

22.

Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.

Morrison AP, Law H, Carter L, Sellers R, Emsley R, Pyle M, French P, Shiers D, Yung AR, Murphy EK, Holden N, Steele A, Bowe SE, Palmier-Claus J, Brooks V, Byrne R, Davies L, Haddad PM.

Lancet Psychiatry. 2018 May;5(5):411-423. doi: 10.1016/S2215-0366(18)30096-8. Epub 2018 Apr 5. Erratum in: Lancet Psychiatry. 2019 Jul;6(7):e16.

23.

Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms.

Firth J, Rosenbaum S, Ward PB, Curtis J, Teasdale SB, Yung AR, Sarris J.

Early Interv Psychiatry. 2018 Oct;12(5):774-783. doi: 10.1111/eip.12544. Epub 2018 Mar 21.

24.

Exploring functional impairment in young people at ultra-high risk for psychosis: A qualitative study.

Cotter J, Bucci S, Drake RJ, Yung AR, Carney R, Edge D.

Early Interv Psychiatry. 2019 Aug;13(4):789-797. doi: 10.1111/eip.12560. Epub 2018 Mar 7.

PMID:
29512314
25.

Netrin-1 Confines Rhombic Lip-Derived Neurons to the CNS.

Yung AR, Druckenbrod NR, Cloutier JF, Wu Z, Tessier-Lavigne M, Goodrich LV.

Cell Rep. 2018 Feb 13;22(7):1666-1680. doi: 10.1016/j.celrep.2018.01.068.

26.

Ultra-high risk phase: A missed opportunity for physical health care.

Carney R, Bradshaw T, Yung AR.

Early Interv Psychiatry. 2018 Apr;12(2):267-268. doi: 10.1111/eip.12493. Epub 2017 Nov 20. No abstract available.

PMID:
29154505
27.

A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.

Qurashi I, Chaudhry IB, Khoso AB, Farooque S, Lane S, Husain MO, Chu S, Sarginson J, Hamarani M, Naqvi HA, Razzaque B, Minhas FA, Yung AR, Deakin JFW, Husain N.

Trials. 2017 Nov 9;18(1):524. doi: 10.1186/s13063-017-2275-y.

28.

The Validity and Value of Self-reported Physical Activity and Accelerometry in People With Schizophrenia: A Population-Scale Study of the UK Biobank.

Firth J, Stubbs B, Vancampfort D, Schuch FB, Rosenbaum S, Ward PB, Firth JA, Sarris J, Yung AR.

Schizophr Bull. 2018 Oct 17;44(6):1293-1300. doi: 10.1093/schbul/sbx149.

29.

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.

Hartmann JA, McGorry PD, Schmidt SJ, Amminger GP, Yuen HP, Markulev C, Berger GE, Chen EYH, de Haan L, Hickie IB, Lavoie S, McHugh MJ, Mossaheb N, Nieman DH, Nordentoft M, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Thompson A, Verma SK, Yung AR, Nelson B.

Psychother Psychosom. 2017;86(5):292-299. doi: 10.1159/000477551. Epub 2017 Sep 14.

30.

Distinct functions for netrin 1 in chicken and murine semicircular canal morphogenesis.

Nishitani AM, Ohta S, Yung AR, Del Rio T, Gordon MI, Abraira VE, Avilés EC, Schoenwolf GC, Fekete DM, Goodrich LV.

Development. 2017 Sep 15;144(18):3349-3360. doi: 10.1242/dev.144519. Epub 2017 Aug 29.

31.

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis - CORRIGENDUM.

Firth J, Stubbs B, Sarris J, Rosenbaum S, Teasdale S, Berk M, Yung AR.

Psychol Med. 2018 Feb;48(3):528. doi: 10.1017/S0033291717001866. Epub 2017 Jul 17. No abstract available.

PMID:
28712367
32.

Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trial.

Fowler D, French P, Banerjee R, Barton G, Berry C, Byrne R, Clarke T, Fraser R, Gee B, Greenwood K, Notley C, Parker S, Shepstone L, Wilson J, Yung AR, Hodgekins J.

Trials. 2017 Jul 11;18(1):315. doi: 10.1186/s13063-017-2062-9.

33.

Ventricular volumes across stages of schizophrenia and other psychoses.

Berger GE, Bartholomeusz CF, Wood SJ, Ang A, Phillips LJ, Proffitt T, Brewer WJ, Smith DJ, Nelson B, Lin A, Borgwardt S, Velakoulis D, Yung AR, McGorry PD, Pantelis C.

Aust N Z J Psychiatry. 2017 Oct;51(10):1041-1051. doi: 10.1177/0004867417715914. Epub 2017 Jul 1.

PMID:
28670977
34.

Challenges in implementing an exercise intervention within residential psychiatric care: A mixed methods study.

Firth J, Carney R, Pownall M, French P, Elliott R, Cotter J, Yung AR.

Ment Health Phys Act. 2017 Mar;12:141-146. doi: 10.1016/j.mhpa.2017.04.004.

35.

Examining the physical health and lifestyle of young people at ultra-high risk for psychosis: A qualitative study involving service users, parents and clinicians.

Carney R, Cotter J, Bradshaw T, Yung AR.

Psychiatry Res. 2017 Sep;255:87-93. doi: 10.1016/j.psychres.2017.05.023. Epub 2017 May 16.

36.

Treatment of people at ultra-high risk for psychosis.

Yung AR.

World Psychiatry. 2017 Jun;16(2):207-208. doi: 10.1002/wps.20424. No abstract available.

37.

Making Early Intervention more equitable.

Yung AR.

Aust N Z J Psychiatry. 2017 May;51(5):534-535. doi: 10.1177/0004867417699474. Epub 2017 Mar 22. No abstract available.

PMID:
28415874
38.

The pro-cognitive mechanisms of physical exercise in people with schizophrenia.

Firth J, Cotter J, Carney R, Yung AR.

Br J Pharmacol. 2017 Oct;174(19):3161-3172. doi: 10.1111/bph.13772. Epub 2017 Apr 20. Review.

39.

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis.

Firth J, Stubbs B, Sarris J, Rosenbaum S, Teasdale S, Berk M, Yung AR.

Psychol Med. 2017 Jul;47(9):1515-1527. doi: 10.1017/S0033291717000022. Epub 2017 Feb 16. Review. Erratum in: Psychol Med. 2018 Feb;48(3):528.

PMID:
28202095
40.

Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysis.

Carney R, Cotter J, Firth J, Bradshaw T, Yung AR.

Acta Psychiatr Scand. 2017 Jul;136(1):5-15. doi: 10.1111/acps.12699. Epub 2017 Feb 7.

41.

How should physical exercise be used in schizophrenia treatment?

Yung AR, Firth J.

Expert Rev Neurother. 2017 Mar;17(3):213-214. doi: 10.1080/14737175.2017.1275571. Epub 2016 Dec 28. No abstract available.

PMID:
28001435
42.

Metacognitive beliefs in the at-risk mental state: A systematic review and meta-analysis.

Cotter J, Yung AR, Carney R, Drake RJ.

Behav Res Ther. 2017 Mar;90:25-31. doi: 10.1016/j.brat.2016.12.004. Epub 2016 Dec 8. Review.

PMID:
27960094
43.

Long-term employment among people at ultra-high risk for psychosis.

Cotter J, Lin A, Drake RJ, Thompson A, Nelson B, McGorry P, Wood SJ, Yung AR.

Schizophr Res. 2017 Jun;184:26-31. doi: 10.1016/j.schres.2016.11.033. Epub 2016 Nov 27.

44.

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP.

JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902.

45.

Bipolar At-Risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition From Depression to Bipolar Disorders.

Scott J, Marwaha S, Ratheesh A, Macmillan I, Yung AR, Morriss R, Hickie IB, Bechdolf A.

Schizophr Bull. 2017 Jul 1;43(4):737-744. doi: 10.1093/schbul/sbw154.

46.

Lifestyle factors may be linked to symptoms of metabolic syndrome in people at risk for psychosis.

Carney R, Bradshaw T, Firth J, Cotter J, Yung AR.

Schizophr Res. 2017 May;183:47-48. doi: 10.1016/j.schres.2016.11.013. Epub 2016 Nov 16. No abstract available.

PMID:
27863933
47.

Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.

McHugh MJ, McGorry PD, Yung AR, Lin A, Wood SJ, Hartmann JA, Nelson B.

Psychol Med. 2017 Mar;47(4):616-626. doi: 10.1017/S0033291716002671. Epub 2016 Nov 8.

PMID:
27821204
48.

Moving beyond the weight-loss paradigm of exercise interventions for mental illness.

Firth J, Vancampfort D, Schuch FB, Yung AR, Stubbs B.

Psychiatry Res. 2016 Dec 30;246:392-393. doi: 10.1016/j.psychres.2016.10.033. Epub 2016 Oct 18. No abstract available.

PMID:
27788458
49.

Netrin1/DCC signaling promotes neuronal migration in the dorsal spinal cord.

Junge HJ, Yung AR, Goodrich LV, Chen Z.

Neural Dev. 2016 Oct 26;11(1):19.

50.

Social cognition in multiple sclerosis: A systematic review and meta-analysis.

Cotter J, Firth J, Enzinger C, Kontopantelis E, Yung AR, Elliott R, Drake RJ.

Neurology. 2016 Oct 18;87(16):1727-1736. Epub 2016 Sep 21. Review.

Supplemental Content

Support Center